Skip to content

Effect of Ajapa Japa meditation on hypertension

Effect of Ajapa Japa on stress and quality of life in the patients of stage 1 hypertension - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/10/059329
Enrollment
92
Registered
2023-10-31
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: Ajapa Japa Meditation: Ajapa Japa is a guided yogic meditation practice, which provides complete physical, mental and emotional relaxation. For the study, this meditation technique was

Sponsors

Department of Kayachikitsa, Faculty of Ayurveda, IMS, BHU
Lead Sponsor
Ayush Acharya
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. The patients who will be diagnosed with stage 1 hypertension with systolic blood pressure =140 mmHg and mm Hg. 2. Patients with adequate hearing acuity. 3. Patients who is willing to sign the consent form. 4. Patients age group with 20-50 years irrespective of sex, religion, occupation and socioeconomic status.

Exclusion criteria

Exclusion criteria: 1. Patient who will be taking any antihypertension and antipsychotic medication. 2. Pregnancy-induced hypertensive patients and lactating mothers. 3. Patients having any other serious illness like coronary arteries disease, cerebrovascular diseases, renal function impairment, etc. 4. Patients having complication of hypertension like retinopathy, nephropathy etc.

Design outcomes

Primary

MeasureTime frame
1 Systolic Blood Pressure 2 Diastolic Blood pressureTimepoint: 12 weeks with 3 follow-ups of every 4th week

Secondary

MeasureTime frame
1 Stress 2 Quality of Life 3 Pulse rate 4 Respiratory rate 5 BMI 6 Weight Timepoint: 12 weeks with 3 follow-ups of every 4th week

Countries

India

Contacts

Public ContactDr Shalini

Institute of Medical Science, BHU

dr.shalini@bhu.ac.in9785520474

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026